| HGNC Family | Phosphodiesterases (PDE) |
| Name | phosphodiesterase 5A, cGMP-specific |
| Description | This gene encodes a cGMP-binding, cGMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family. This phosphodiesterase specifically hydrolyzes cGMP to 5'-GMP. It is involved in the regulation of intracellular concentrations of cyclic nucleotides and is important for smooth muscle relaxation in the cardiovascular system. Alternative splicing of this gene results in three transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPhosphodiesterase 5A (PDE5A) is a cGMP‐specific enzyme that plays a central role in modulating intracellular cyclic guanosine monophosphate (cGMP) levels by hydrolyzing cGMP, thus terminating nitric oxide (NO)/cGMP signaling. Structural and biochemical studies have revealed that PDE5A contains distinct catalytic and regulatory GAF domains that bind cGMP allosterically, and its activity is further controlled by phosphorylation (which increases its affinity for cGMP), cyclic nucleotide levels, and even by direct binding of inhibitors. These molecular features not only explain its responsiveness to drugs—such as sildenafil, tadalafil, and vardenafil—but also illustrate how PDE5A serves as a tunable negative feedback regulator in diverse cell types."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "9"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn smooth muscle tissues such as the corpus cavernosum, vas deferens, bladder, and vascular endothelium, PDE5A’s cGMP‐degrading activity is critical for regulating muscle tone and contractility. In the corpora cavernosa, for instance, androgen‐dependent upregulation of PDE5A explains its high expression in male genital tissue and underpins the efficacy of PDE5 inhibitors in treating erectile dysfunction, while in the bladder and prostate, PDE5A modulates NO/cGMP signaling to affect smooth muscle relaxation and lower urinary tract function. Moreover, in cardiac myocytes, increased PDE5A expression (or its enhanced activation via oxidative stress and phosphorylation) has been linked to pathological remodeling, hypertrophy, and heart failure, emphasizing its significance in cardiovascular physiology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "17"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its classical roles in smooth muscle and cardiovascular tissues, dysregulation of PDE5A is increasingly recognized in non‐canonical settings including cancer and neural tissues. In melanoma cells, oncogenic BRAF downregulates PDE5A, leading to elevated cGMP and intracellular Ca²⁺ that drive invasive behavior. In several cancers—such as breast, thyroid, colon, glioblastoma, and even Hodgkin lymphoma—altered PDE5A expression correlates with changes in cell proliferation, survival, and apoptotic pathways, making it a promising target for chemoprevention and anticancer strategies. In platelets and neurons, compartmentalized regulation of PDE5A (and the development of biosensors based on its GAF domains) underscores its broader role in fine-tuning cellular responses to NO and cGMP. This multifunctional profile of PDE5A, modulated by its expression levels, post-translational modifications, and inhibitor binding, establishes it as a key therapeutic target for conditions ranging from pulmonary hypertension, erectile dysfunction, and lower urinary tract symptoms to cardiac hypertrophy, neurodegeneration, and cancer."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "32"}]}, {"type": "t", "text": ""}]}]}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "C-S Lin, S Chow, A Lau, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Impot Res (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.ijir.3900802"}], "href": "https://doi.org/10.1038/sj.ijir.3900802"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11896473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11896473"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Florian Mullershausen, Andreas Friebe, Robert Feil, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200211041"}], "href": "https://doi.org/10.1083/jcb.200211041"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12604588"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12604588"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Byung-Je Sung, Kwang Yeon Hwang, Young Ho Jeon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature01914"}], "href": "https://doi.org/10.1038/nature01914"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12955149"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12955149"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Qing Huai, Yudong Liu, Sharron H Francis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M311556200"}], "href": "https://doi.org/10.1074/jbc.M311556200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14668322"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14668322"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Annamaria Morelli, Sandra Filippi, Rosa Mancina, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2003-1699"}], "href": "https://doi.org/10.1210/en.2003-1699"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14764637"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14764637"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "R Mancina, S Filippi, M Marini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Hum Reprod (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/molehr/gah143"}], "href": "https://doi.org/10.1093/molehr/gah143"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15640438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15640438"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "John Wharton, Julian W Strange, Gigi M O Møller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Respir Crit Care Med (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1164/rccm.200411-1587OC"}], "href": "https://doi.org/10.1164/rccm.200411-1587OC"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15817798"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15817798"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Roya Zoraghi, Jackie D Corbin, Sharron H Francis "}, {"type": "b", "children": [{"type": "t", "text": "Phosphodiesterase-5 Gln817 is critical for cGMP, vardenafil, or sildenafil affinity: its orientation impacts cGMP but not cAMP affinity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M510372200"}], "href": "https://doi.org/10.1074/jbc.M510372200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16407275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16407275"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ching-Shwun Lin, Guiting Lin, Zhong-Cheng Xin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression, distribution and regulation of phosphodiesterase 5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Pharm Des (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/138161206778343064"}], "href": "https://doi.org/10.2174/138161206778343064"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17017938"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17017938"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Sandra Filippi, Annamaria Morelli, Peter Sandner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization and functional role of androgen-dependent PDE5 activity in the bladder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2006-1079"}], "href": "https://doi.org/10.1210/en.2006-1079"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17138653"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17138653"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Kabir Hassan Biswas, Shailaja Sopory, Sandhya S Visweswariah "}, {"type": "b", "children": [{"type": "t", "text": "The GAF domain of the cGMP-binding, cGMP-specific phosphodiesterase (PDE5) is a sensor and a sink for cGMP."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi702025w"}], "href": "https://doi.org/10.1021/bi702025w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18293931"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18293931"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Lindsay S Wilson, Hisham S Elbatarny, Scott W Crawley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0804738105"}], "href": "https://doi.org/10.1073/pnas.0804738105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18757735"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18757735"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Peter Pokreisz, Sara Vandenwijngaert, Virginie Bito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.108.822072"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.108.822072"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19139381"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19139381"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Norimichi Koitabashi, Takeshi Aiba, Geoffrey G Hesketh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Cell Cardiol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yjmcc.2009.11.015"}], "href": "https://doi.org/10.1016/j.yjmcc.2009.11.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19961855"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19961855"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Heather N Tinsley, Bernard D Gary, Adam B Keeton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-09-0758"}], "href": "https://doi.org/10.1158/1535-7163.MCT-09-0758"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19996273"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19996273"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Zhongbing Lu, Xin Xu, Xinli Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oxidative stress regulates left ventricular PDE5 expression in the failing heart."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.109.906818"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.109.906818"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20308615"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20308615"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Huanchen Wang, Howard Robinson, Hengming Ke "}, {"type": "b", "children": [{"type": "t", "text": "Conformation changes, N-terminal involvement, and cGMP signal relay in the phosphodiesterase-5 GAF domain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.141614"}], "href": "https://doi.org/10.1074/jbc.M110.141614"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20861010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20861010"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Imanol Arozarena, Berta Sanchez-Laorden, Leisl Packer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2010.10.029"}], "href": "https://doi.org/10.1016/j.ccr.2010.10.029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21215707"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21215707"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Milena A Gebska, Blake K Stevenson, Anna R Hemnes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cardiovasc Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/cvr/cvq410"}], "href": "https://doi.org/10.1093/cvr/cvq410"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21421555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21421555"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Heather N Tinsley, Bernard D Gary, Adam B Keeton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/β-catenin-mediated transcription in human breast tumor cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Prev Res (Phila) (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1940-6207.CAPR-11-0095"}], "href": "https://doi.org/10.1158/1940-6207.CAPR-11-0095"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21505183"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21505183"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Stefan Nagel, Björn Schneider, Andreas Rosenwald, et al. "}, {"type": "b", "children": [{"type": "t", "text": "t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.20920"}], "href": "https://doi.org/10.1002/gcc.20920"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21987443"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21987443"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Fatemeh Karami-Tehrani, Marzieh Moeinifard, Mahmoud Aghaei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of PDE5 and PDE9 expression in benign and malignant breast tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Med Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.arcmed.2012.08.006"}], "href": "https://doi.org/10.1016/j.arcmed.2012.08.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22960860"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22960860"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Karyn B Cahill, Jonathan H Quade, Karen L Carleton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of amino acid residues responsible for the selectivity of tadalafil binding to two closely related phosphodiesterases, PDE5 and PDE6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.389189"}], "href": "https://doi.org/10.1074/jbc.M112.389189"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23033484"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23033484"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Sara Vandenwijngaert, Peter Pokreisz, Hadewich Hermans, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased cardiac myocyte PDE5 levels in human and murine pressure overload hypertrophy contribute to adverse LV remodeling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0058841"}], "href": "https://doi.org/10.1371/journal.pone.0058841"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23527037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23527037"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Daniela Puzzo, Carla Loreto, Salvatore Giunta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of phosphodiesterase-5 inhibition on apoptosis and beta amyloid load in aged mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Aging (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neurobiolaging.2013.09.002"}], "href": "https://doi.org/10.1016/j.neurobiolaging.2013.09.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24112792"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24112792"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Waihay J Wong, Theresa Richardson, John T Seykora, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-inducible factors regulate filaggrin expression and epidermal barrier function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jid.2014.283"}], "href": "https://doi.org/10.1038/jid.2014.283"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24999590"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24999590"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Marialuisa Sponziello, Antonella Verrienti, Francesca Rosignolo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrine (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12020-015-0586-x"}], "href": "https://doi.org/10.1007/s12020-015-0586-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25837309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25837309"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Nan Li, Xi Chen, Bing Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.4741"}], "href": "https://doi.org/10.18632/oncotarget.4741"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26299804"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26299804"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Wenhao Zhang, Ning Zang, Yaoming Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep17888"}], "href": "https://doi.org/10.1038/srep17888"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26657792"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26657792"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Andrew F Teich, Mikako Sakurai, Mitesh Patel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Alzheimers Dis (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/JAD-151104"}], "href": "https://doi.org/10.3233/JAD-151104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26967220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26967220"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Valeriana Cesarini, Maurizio Martini, Lucia Ricci Vitiani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.14656"}], "href": "https://doi.org/10.18632/oncotarget.14656"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28099939"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28099939"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Jacob P Thyssen, Ivone Jakasa, Christoph Riethmüller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Filaggrin Expression and Processing Deficiencies Impair Corneocyte Surface Texture and Stiffness in Mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jid.2019.07.716"}], "href": "https://doi.org/10.1016/j.jid.2019.07.716"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31479664"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31479664"}]}]}]}
|
| Synonyms | CGB-PDE, PDE5, CN5A |
| Proteins | PDE5A_HUMAN |
| NCBI Gene ID | 8654 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PDE5A has 7,605 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 120 datasets.
Click the + buttons to view associations for PDE5A from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PDE5A gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PDE5A gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PDE5A gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PDE5A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PDE5A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PDE5A gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PDE5A gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PDE5A gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PDE5A gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PDE5A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PDE5A gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with PDE5A protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PDE5A gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PDE5A gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PDE5A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PDE5A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PDE5A gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PDE5A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing PDE5A protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PDE5A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PDE5A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PDE5A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PDE5A gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PDE5A gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PDE5A gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with PDE5A gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of PDE5A protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PDE5A gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PDE5A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PDE5A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PDE5A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PDE5A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for PDE5A protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PDE5A gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PDE5A gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PDE5A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PDE5A from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with PDE5A gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with PDE5A gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PDE5A gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PDE5A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PDE5A from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PDE5A gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PDE5A gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PDE5A gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PDE5A gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PDE5A gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PDE5A gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PDE5A gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PDE5A gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PDE5A protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PDE5A gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by PDE5A gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by PDE5A gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PDE5A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PDE5A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PDE5A gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of PDE5A gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding PDE5A receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PDE5A gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with PDE5A gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with PDE5A gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PDE5A gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for PDE5A protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PDE5A gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PDE5A gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of PDE5A protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PDE5A gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for PDE5A from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PDE5A gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by PDE5A gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PDE5A protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PDE5A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PDE5A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PDE5A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate PDE5A protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways | pathways involving PDE5A protein from the KEGG Pathways dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PDE5A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PDE5A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PDE5A gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PDE5A gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PDE5A gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PDE5A gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing PDE5A protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PDE5A protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PDE5A gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting PDE5A gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PDE5A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PDE5A gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PDE5A gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PDE5A gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PDE5A from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PDE5A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PDE5A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PDE5A protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PDE5A protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with PDE5A protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate PDE5A protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| Reactome Pathways 2014 | pathways involving PDE5A protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving PDE5A protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PDE5A gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PDE5A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PDE5A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PDE5A gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PDE5A gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with PDE5A protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of PDE5A gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of PDE5A gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of PDE5A gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PDE5A gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PDE5A gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PDE5A gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PDE5A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PDE5A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PDE5A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PDE5A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PDE5A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PDE5A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving PDE5A protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PDE5A protein from the WikiPathways Pathways 2024 dataset. | |